Advances in Non-Animal Testing Approaches towards Accelerated Clinical Translation of Novel Nanotheranostic Therapeutics for Central Nervous System Disorders.

While there is an increasing trend away from the dogmatic principles of relying on the EPR effect for nanomaterials and the properties that govern preferential entry across the BBB, elucidation of the various receptor-mediated and transport processes has not been entirely realised.

also in 63,971 other papers